학술논문
MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway
Document Type
Article
Author
Source
In: Oncotarget . (Oncotarget, 2022, 13(1):1217-1236)
Subject
Language
English
ISSN
19492553